Anna Ritá Migliaccio

Istituto di Nanotecnologia — Italy

Medicine · Health Sciences

43h-index14.0kcitations409works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Myeloproliferative Neoplasms: Diagnosis and Treatment(175), Erythrocyte Function and Pathophysiology(103), Platelet Disorders and Treatments(90), Chronic Myeloid Leukemia Treatments(64), Hemoglobinopathies and Related Disorders(46)

Publications405 total

Supplementary Figure S3 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025Open Access
Supplementary Figure S1 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025Open Access
Supplementary Figure S5 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025Open Access
Supplementary Table S3 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025Open Access
Supplementary Table S1 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025Open Access
Supplementary Figure S9 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025Open Access
Supplementary Figure S7 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025Open Access
Supplementary Figure S2 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025Open Access
Supplementary Table S2 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025Open Access
Supplementary Table S4 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025Open Access
Supplementary Figure S4 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025Open Access
Supplementary Figure S6 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025Open Access
Supplementary Figure S8 from A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
2025Open Access
Phase II study of reparixin in patients with myelofibrosis. myeloproliferative neoplasms research consortium (MPN-RC) 120 trial
Blood·2025Open Access
Megakaryocytes engage in emperipolesis with neutrophils and emperipolesis by the immune MK subset leads to efferocytosis and is exacerbated by CXCR1/2 activation in myelofibrosis
Blood·2025
L’USO DEL LINGUAGGIO INCLUSIVO NELL’INSEGNAMENTO DELLE LINGUE:
Dykinson eBooks·2025
Red cells: not only hemoglobin – plasma membranes are also of paramount importance
Current Opinion in Hematology·2025
Wnt-dependent spatiotemporal reprogramming of bone marrow niches drives fibrosis
2025· 1 cited
<i>Distinctive Alterations in the Emperipolesis between Neutrophils and Megakaryocytes from the Bone Marrow of Gata1low Mice Documented By Time-Lapse Observations</i>
Blood·2024
Editorial: Editors’ showcase: red cells, iron and erythropoiesis
Frontiers in Hematology·2024Open Access
page 1 of 21Next →

Frequent Co-authors

Giovanni Migliaccio(25), Alessandro M. Vannucchi(11), Fabrizio Martelli(8), Maria Zingariello(7), Lilian Varricchio(7), Carolyn Whitsett(7), Rosa Alba Rana(6), Massimo Sanchez(6), Francesca Masiello(6), Cladd E. Stevens(5), Lucia Bianchi(5), Francesco Paoletti(5), Ronald Hoffman(5), Carmelita Carrier(4), John W. Adamson(4), N. Ludy Dobrila(4), J W Adamson(4), R Lorenzini(4), Angela Di Baldassarre(4), Thalia Papayannopoulou(4)